Report

Identification of Vaccine Candidates Against Serogroup B Meningococcus by Whole-Genome Sequencing

Science  10 Mar 2000:
Vol. 287, Issue 5459, pp. 1816-1820
DOI: 10.1126/science.287.5459.1816

You are currently viewing the abstract.

View Full Text
As a service to the community, AAAS/Science has made this article free with registration.

Abstract

Neisseria meningitidis is a major cause of bacterial septicemia and meningitis. Sequence variation of surface-exposed proteins and cross-reactivity of the serogroup B capsular polysaccharide with human tissues have hampered efforts to develop a successful vaccine. To overcome these obstacles, the entire genome sequence of a virulent serogroup B strain (MC58) was used to identify vaccine candidates. A total of 350 candidate antigens were expressed in Escherichia coli, purified, and used to immunize mice. The sera allowed the identification of proteins that are surface exposed, that are conserved in sequence across a range of strains, and that induce a bactericidal antibody response, a property known to correlate with vaccine efficacy in humans.

  • * These authors contributed equally to this work.

  • To whom correspondence should be addressed. E-mail: Rino_Rappuoli{at}biocine.it

View Full Text

Cited By...